Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Effect of Dimethyl Sulphoxides as Permeation Enhancer on Transdermal Patch of Nebivolol Hydrochloride


Affiliations
1 Department of Pharmaceutics, Gyan Vihar School of Pharmacy, SGVU, Jaipur, India
2 Department of Pharmaceutical Chemistry, Lordshiva College of Pharmacy, Sirsa, Haryana, India
     

   Subscribe/Renew Journal


A matrix type transdermal patch for delivery of Nebivolol hydrochloride (NEB), is unique as a beta-blocker. Studies were carried out to investigate the effect of permeation enhancers on the in vitro permeation of Nebivolol hydrochloride across rat skin. Films were prepared by using Eudragit RS100 (ERS100) and hydroxy propyl methyl cellulose (HPMC K100M) polymers by incorporating polypropylene glycol (PEG 400) as plasticizer using solvent evaporating method. A total of eight formulations were prepared by using same drug and different polymer ratio and some formulation prepared without (E1-E4)/with (F1-F4) Dimethyl sulphoxides (DMSO) as permeation enhancers in same concentrations. The maximum percent of drug permeation was observed with ERS100 and HPMC K100M (2:8) monolithic system containing 20% Dimethyl sulphoxides (F1). The in vitro release studies revealed that Dimethyl sulphoxides showed better permeation enhancement than without DMSO and the release was sustained up to 48 h and it follows higuchi kinetics. All the films were found to be stable at temperature of 40±2°C and 75±5% relative humidity (RH) as per the international conference on harmonization (ICH) guidelines (Zone IV) for the period of six months with respect to their physical parameters.

Keywords

Permeation Enhancer, Polymers, Transdermal Patch, Nebivolol Hydrochloride, Dimethyl Sulphoxides.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Kumar VS, Niranjan SK, Irchhaiya R, Kumar N, Ali A. A novel transdermal drug delivery system. Int Res J Pharm 3(8);2012:39-44.
  • Hadgraft J, Williams DG, Allan G. Mechanisms of action and clinical effect. In Pharmaceutical Skin Penetration Enhancement, Walters KA, Hadgraft J, Editors., Marcel Dekker: New York, NY, USA, 1993; pp. 175-197.
  • Charoo NA, Shamsher AAA, Kohli K, Pillai K, Rahman K. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (ocinum sanctum) and turpentine oil. Colloid. Surface. B 65;2008: 300-307.
  • Walker RB, Smith EW. The role of percutaneous penetration enhancers. Adv. Drug Deliver. Rev. 18;1996:295-301.
  • Lizelle TF, Minja G, Jeanetta DP, Josias HH. Transdermal Drug Delivery Enhancement by Compounds ofNatural Origin. Molecules 16;2011:10507-540.
  • Sinha VR, Kaur MP. Permeation Enhancers for Transdermal Drug Delivery. Drug Dev Ind Pharm 26(11);2000:1131–40.
  • Singh J, Tripathi KP, Sakya TR. Effect of penetration enhancers on the in vitro transport of ephedrine through rat skin and human epidermis from matrix based transdermal formulations. Drug Dev Ind Pharm 19;1993:1623.
  • Kai T, Nakazono M, Kurosaki Y, Nakayama T, Kimura T. Keratinized epithelial transport of beta-blocking agents, III : Evaluation of enhancing effect on percutaneous absorption using model lipid liposomes. Biol Pharm Bull 16;1993:801.
  • DMSO General Information, Available from: http://www.herbalremedies.com/dmso-information.html. [Last update on 21 Nov. 2012].
  • Singhla V, Saini S, Singh G, Rana AC, Joshi B. Penetration enhancers: A novel strategy for enhancing transdermal drug delivery. Int Res J Pharm 2(12);2011:32-36.
  • Kavitha K, More RM, Patel DM, Sandeep DS, Ganesh NS. Chemical permeation enhancers for transdermal drug delivery: A brief review Der Pharmacia Lettre 2(6);2010:358-65.
  • Anigbogu AN, Williams AC, Barry BW, Edwards HG. Fourier transform raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum. Int J Pharm 125(2);1995:265-82.
  • Gupta JRD, Tripathi P, Irchhiaya R, Garud N, Dubey P, Patel JR. Formulation and evaluation of matrix type transdermal patches of Glibenclamide. Int J Pharm Sci Drug Res 1;2009:46-50.
  • Patel HJ, Patel JS, Patel KD. Transdermal Patch for Ketotifen Fumarate (KTF) as Asthmatic Drug. Int J Pharm Tech Res.1;2009:1297-1304.
  • Gannu R, Vamshi VY, Kishan V, Rao YM. Development of Nitrendipine Transdermal Patches: In vitro and Ex vivo Characterization. Curr Drug Deliv.4;2007:69-76.
  • Devi VK, Saisivam S, Maria GR, Deepti PU. Design and Evaluation of Matrix Diffusion Controlled Transdermal Patches of Verapamil Hydrochloride, Drug Dev Ind Pharm. 29(5);2003:495-503.
  • Nyqvist H, Saturated salt solutions for maintaining specified relative humidities. Int J Pharm. Tech and Prod. Mfr. 4;1983:47-48.

Abstract Views: 369

PDF Views: 90




  • Effect of Dimethyl Sulphoxides as Permeation Enhancer on Transdermal Patch of Nebivolol Hydrochloride

Abstract Views: 369  |  PDF Views: 90

Authors

Vijay Singh Jatav
Department of Pharmaceutics, Gyan Vihar School of Pharmacy, SGVU, Jaipur, India
Jitendra Singh Saggu
Department of Pharmaceutical Chemistry, Lordshiva College of Pharmacy, Sirsa, Haryana, India
Ashish Kumar Sharma
Department of Pharmaceutics, Gyan Vihar School of Pharmacy, SGVU, Jaipur, India
Santosh Kumar Singh
Department of Pharmaceutics, Gyan Vihar School of Pharmacy, SGVU, Jaipur, India

Abstract


A matrix type transdermal patch for delivery of Nebivolol hydrochloride (NEB), is unique as a beta-blocker. Studies were carried out to investigate the effect of permeation enhancers on the in vitro permeation of Nebivolol hydrochloride across rat skin. Films were prepared by using Eudragit RS100 (ERS100) and hydroxy propyl methyl cellulose (HPMC K100M) polymers by incorporating polypropylene glycol (PEG 400) as plasticizer using solvent evaporating method. A total of eight formulations were prepared by using same drug and different polymer ratio and some formulation prepared without (E1-E4)/with (F1-F4) Dimethyl sulphoxides (DMSO) as permeation enhancers in same concentrations. The maximum percent of drug permeation was observed with ERS100 and HPMC K100M (2:8) monolithic system containing 20% Dimethyl sulphoxides (F1). The in vitro release studies revealed that Dimethyl sulphoxides showed better permeation enhancement than without DMSO and the release was sustained up to 48 h and it follows higuchi kinetics. All the films were found to be stable at temperature of 40±2°C and 75±5% relative humidity (RH) as per the international conference on harmonization (ICH) guidelines (Zone IV) for the period of six months with respect to their physical parameters.

Keywords


Permeation Enhancer, Polymers, Transdermal Patch, Nebivolol Hydrochloride, Dimethyl Sulphoxides.

References